CHEN-HUA LIUYIH-SHARNG CHENSHOEI-SHEN WANGJIA-HORNG KAO2019-11-272019-11-2720170929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009289933&doi=10.1016%2fj.jfma.2016.12.005&partnerID=40&md5=00e31818adb4f282be6ea7aee04f57e9https://scholars.lib.ntu.edu.tw/handle/123456789/433970[SDGs]SDG3alanine aminotransferase; alkaline phosphatase; aspartate aminotransferase; bilirubin; gamma glutamyltransferase; ledipasvir plus sofosbuvir; virus RNA; antivirus agent; benzimidazole derivative; fluorene derivative; ledipasvir, sofosbuvir drug combination; uridine phosphate; acute kidney failure; adult; alanine aminotransferase blood level; alkaline phosphatase blood level; antiviral therapy; aspartate aminotransferase blood level; bilirubin blood level; case report; cholestatic hepatitis; drug efficacy; gamma glutamyl transferase blood level; heart infarction; heart transplantation; hemodialysis; hepatic encephalopathy; hepatitis C; Hepatitis C virus; human; jaundice; Letter; liver transplantation; male; middle aged; oliguria; postoperative infection; sustained virologic response; acute kidney failure; analogs and derivatives; complication; heart failure; heart infarction; hepatic encephalopathy; hepatitis C; liver function test; pathophysiology; procedures; treatment outcome; Acute Kidney Injury; Antiviral Agents; Benzimidazoles; Fluorenes; Heart Failure; Heart Transplantation; Hepatic Encephalopathy; Hepatitis C; Humans; Liver Function Tests; Male; Middle Aged; Myocardial Infarction; Treatment Outcome; Uridine Monophosphateletter10.1016/j.jfma.2016.12.005280890922-s2.0-85009289933